Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duvelisib and Nivolumab in Advanced Unresectable Melanoma
NCT04688658Phase 2Terminated
- Start
- Oct 2021
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of duvelisib in melanoma. Started Oct 2021; status: terminated.
02
Drugs
duvelisib
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT04688658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04688658.